SUBSCRIPTION AGREEMENT
SUBSCRIPTION
AGREEMENT (this “Agreement”) made as of the last date set forth on the signature
page hereof between Cornerstone Pharmaceuticals, Inc. (the “Company”), and Xxxxx
Xxxxxxxx and A. Xxxxxx Xxxxx the undersigned (individually each a Subscriber
and
Jointly the “Subscribers”).
For all
Units purchased jointly by Subscribers 85% shall be attributed to A. Xxxxxx
Xxxxx and 15% shall be attributed to Xxxxx Xxxxxxxx.
WITNESSETH:
WHEREAS,
the parties desire that, upon the terms and conditions contained herein, the
Company shall sell and issue and the Subscribers shall purchase up to 1,250,000
units each consisting of four shares of the Company’s common stock, par value
$.001 per share (“Common Stock”) and three warrants (“Warrants”) exercisable at
$1.10 per share in accordance with the terms of the attached draft warrant
(the
Warrants and Common Stock are hereinafter referred to as the “Units”); and, in a
private offering (the “Offering”); and
WHEREAS,
the purchase price for each Unit shall be $4.00; and
WHEREAS,
the Subscriber desires to purchase the Units on the terms conditions of this
Agreement;
NOW,
THEREFORE, in consideration of the premises and the mutual representations
and
covenants hereinafter set forth, the parties hereto do hereby agree as
follows:
I.
|
SUBSCRIPTION
FOR UNITS AND REPRESENTATIONS BY
SUBSCRIBER
|
1.1 Subject
to the terms and conditions hereinafter set forth, from time to time and up
until October 31, 2008 the Company may send the Subscribers written notice
(said
notice can be given by fax, email or by regular USPS mail) requesting that
the
Subscribers purchase the number of Units stated in such notice(s) at a purchase
price of $4.00 per unit. Said notice can not be given more frequently than
once
per any thirty (30) day period (the “Company’s Notice”). The Subscribers hereby
irrevocably subscribe for and agree to purchase from the Company the number
of
Units set forth in the Company’s Notice (up to an aggregate of 1,250,000 Units
for all notices). In each Company Notice Company shall request that Subscriber
purchase no less than 100,000 units and no more than 200,000 units in any given
Notice period. Subscriber shall wire within thirty days of the receipt of the
Company’s Notice an amount equal to the Company’s Notice. (the “Subscription
Amount”). Within thirty (30) business days of the Company’s receipt of the
Subscription Amount, the Company shall send to the Subscribers stock
certificates representing the Common Stock and Warrants purchased. The Company
hereby takes into account the 356,250 Units already subscribed for by Subscriber
through the date of the signing of this Agreement.
1.2 The
Subscriber recognizes that the purchase of the Units involves a high degree
of
risk including, but not limited to, the following: (a) the Company remains
an
early stage business with limited operating history and requires substantial
funds in addition to the proceeds of the Offering; (b) an investment in the
Company is highly speculative, and only investors who can afford the loss of
their entire investment should consider investing in the Company and the Units;
(c) the Subscribers may not be able to liquidate their investment; (d)
transferability of the Units, including the Common Stock and Warrants contained
therein and the Common Stock issuable upon the exercise of the Warrants, is
extremely limited; (e) in the event of a disposition of the Units (or the Common
Stock, Warrants or Common Stock issuable upon the exercise of the Warrants,
the
Subscribers could sustain the loss of their entire investment; (f) the Company
has not paid any dividends since its inception and does not anticipate paying
any dividends, and (g) the shares of the Company’s Common Stock are junior to
the rights and preferences of the shares of Series A Preferred Stock which
are
currently outstanding and the Company may issue additional securities in the
future which have rights and preferences that are senior to those of the Common
Stock.
1.3 Each
Subscriber represents that such Subscriber is an “accredited investor” as such
term is defined in Rule 501 of Regulation D (“Regulation D”) promulgated under
the Securities Act of 1933, as amended (the “Securities Act”), as indicated by
the Subscriber’s responses to the questions contained in Article VII hereof, and
that the Subscriber is able to bear the economic risk of an investment in the
in
the Units. The Subscriber hereby acknowledges and represents that (a) the
Subscriber has knowledge and experience in business and financial matters,
prior
investment experience, including investment in securities that are non-listed,
unregistered and/or not traded on a national securities exchange nor on the
National Association of Securities Dealers, Inc. (the “NASD”) automated
quotation system (“NASDAQ”), or the Subscriber has employed the services of a
“purchaser representative” (as defined in Rule 501 of Regulation D), attorney
and/or accountant to read all of the documents furnished or made available
by
the Company to the Subscriber and to evaluate the merits and risks of such
an
investment in the Units on the Subscriber’s behalf; (b) the Subscriber
recognizes the highly speculative nature of this investment; and (c) the
Subscriber is able to bear the economic risk that the Subscriber hereby
assumes.
1.4 The
Subscriber hereby acknowledges receipt and careful review of this Agreement,
including all exhibits thereto, and any documents which may have been made
available upon request as reflected therein (collectively referred to as the
“Offering Materials”) and hereby represents that the Subscriber has been
furnished by the Company during the course of the Offering with all information
regarding the Company, the terms and conditions of the Offering and any
additional information that the Subscriber has requested or desired to know,
and
has been afforded the opportunity to ask questions of and receive answers from
duly authorized officers or other representatives of the Company concerning
the
Company and the terms and conditions of the Offering.
1.5
(a) In
making
the decision to invest in the Units the Subscriber has relied solely upon the
information provided by the Company in the Offering Materials. To the extent
necessary, the Subscriber has retained, at its own expense, and relied upon
appropriate professional advice regarding the investment, tax and legal merits
and consequences of this Agreement and the purchase of the Units hereunder.
The
Subscriber disclaims reliance on any statements made or information provided
by
any person or entity in the course of Subscriber’s consideration of an
investment in the Units other than the Offering Materials.
2
(b) The
Subscriber represents that (i) the Subscriber was contacted regarding the sale
of the Units by the Company (or an authorized agent or representative thereof)
with whom the Subscriber had a prior substantial pre-existing relationship
and
(ii) no Units were offered or sold to it by means of any form of general
solicitation or general advertising, and in connection therewith, the Subscriber
did not (A) receive or review any advertisement, article, notice or other
communication published in a newspaper or magazine or similar media or broadcast
over television or radio, whether closed circuit, or generally available; or
(B)
attend any seminar meeting or industry investor conference whose attendees
were
invited by any general solicitation or general advertising.
1.6 The
Subscriber hereby represents that the Subscriber, either by reason of the
Subscriber’s business or financial experience or the business or financial
experience of the Subscriber’s professional advisors (who are unaffiliated with
and not compensated by the Company or any affiliate or selling agent of the
Company, directly or indirectly), has the capacity to protect the Subscriber’s
own interests in connection with the transaction contemplated
hereby.
1.7 The
Subscriber hereby acknowledges that the Offering has not been reviewed by the
United States Securities and Exchange Commission (the “SEC”) nor any state
regulatory authority since the Offering is intended to be exempt from the
registration requirements of Section 5 of the Securities Act pursuant to
Regulation D promulgated thereunder. The Subscriber understands that the Units,
including the Common Stock, the Warrants the Common Stock issuable upon exercise
of the Warrants (the Units, the Common Stock, the Warrants and the Common Stock
issuable upon exercise of the Common Stock are hereinafter sometimes referred
to
as the “Securities”), have not been registered under the Securities Act or under
any state securities or “blue sky” laws and agrees not to sell, pledge, assign
or otherwise transfer or dispose of the Units unless they are registered under
the Securities Act and under any applicable state securities or “blue sky” laws
or unless an exemption from such registration is available.
1.8 The
Subscriber understands that the Securities have not been registered under the
Securities Act by reason of a claimed exemption under the provisions of the
Securities Act that depends, in part, upon the Subscriber’s investment
intention. In this connection, the Subscriber hereby represents that the
Subscriber is purchasing the Units for the Subscriber’s own account for
investment and not with a view toward the resale or distribution to others.
The
Subscriber, if an entity, further represents that it was not formed for the
purpose of purchasing the Units.
1.9 The
Subscriber understands that there is no public market for the Common Stock
or
any other securities of the Company and that no market may develop for any
the
Common Stock or any other securities of the Company. The Subscriber understands
that even if a public market develops for such Common Stock, Rule 144 (“Rule
144”) promulgated under the Securities Act requires for non-affiliates, among
other conditions, a one-year holding period prior to the resale (in limited
amounts) of securities acquired in a non-public offering without having to
satisfy the registration requirements under the Securities Act. The Subscriber
understands and hereby acknowledges that the Company is under no obligation
to
register any of the Securities under the Securities Act or any state securities
or “blue sky” laws other than as set forth in Article V.
3
1.10 The
Subscriber consents to the placement of a legend on any certificate or other
document evidencing the Securities that such Securities have not been registered
under the Securities Act or any state securities or “blue sky” laws and setting
forth or referring to the restrictions on transferability and sale thereof
contained in this Agreement. The Subscriber is aware that the Company will
make
a notation in its appropriate records with respect to the restrictions on the
transferability of such Securities. The legend to be placed on each certificate
and each Warrant shall be in form substantially similar to the
following:
“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES OR “BLUE
SKY LAWS”, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR
HYPOTHECATED ABSENT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR
COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR UNLESS THE COMPANY
HAS
RECEIVED AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY AND
ITS
COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.”
1.11 The
Subscriber understands that the Company will review this Agreement and is hereby
given authority by the Subscriber to call Subscriber’s bank or place of
employment or otherwise review the financial standing of the Subscriber; and
it
is further agreed that the Company, at its sole discretion, reserve the
unrestricted right, without further documentation or agreement on the part
of
the Subscriber.
1.12 The
Subscriber hereby represents that the address of the Subscriber furnished by
Subscriber on the signature page hereof is the Subscriber’s principal residence
if Subscriber is an individual or its principal business address if it is a
corporation or other entity.
1.13 The
Subscriber represents that the Subscriber has full power and authority
(corporate, statutory and otherwise) to execute and deliver this Agreement
and
to purchase the Securities. This Agreement constitutes the legal, valid and
binding obligation of the Subscriber, enforceable against the Subscriber in
accordance with its terms.
1.14 If
the
Subscriber is a corporation, partnership, Limited Liability Company, trust,
employee benefit plan, individual retirement account, Xxxxx Plan, or other
tax-exempt entity, it is authorized and qualified to invest in the Company
and
the person signing this Agreement on behalf of such entity has been duly
authorized by such entity to do so.
1.15 The
Subscriber acknowledges that if he or she is a Registered Representative of
an
NASD member firm, he or she must give such firm the notice required by the
NASD’s Rules of Fair Practice, receipt of which must be acknowledged by such
firm in Section 7.4 below.
4
1.16 The
Subscriber acknowledges that at such time, if ever, as the Securities are
registered (as such term is defined in Article V hereof), sales of the
Securities will be subject to state securities laws.
1.17 b) Subject
to the provision below, the Subscriber hereby agrees that from the earlier
to
occur of (i) the date of the initial public offering of the Common Stock (the
“IPO”) or (ii) the first date (the “Trading Date”) on which the Common Stock
trades on a national securities exchange or (on the NASDAQ) (a “Trading Event”)
and continuing for a period of 180 days thereafter or such longer period as
may
be requested by the underwriter or underwriters, in the case of an IPO (the
“Lock-Up Period”), the Subscriber will not, without the prior written consent of
the Company, offer, pledge, sell, contract to sell, grant any option for the
sale of, or otherwise dispose of, directly or indirectly, the Registrable Shares
(as defined in Section 5.1) purchased or acquired by the Subscriber. In
addition, the Subscriber agrees that during the period from the date that
Subscriber was first contacted with respect to the potential purchase of the
Units through the last date upon which Subscriber holds any Units or Registrable
Shares, the Subscriber will not directly or indirectly, through related parties,
affiliates or otherwise sell “short” or “short against the box” (as those terms
are generally understood) any equity security of the Company.
(b)
RESERVED
(c) In
order
to enforce the foregoing covenant, the Company may impose stop-transfer
instructions with respect to the Registrable Shares (as defined below) of each
Holder (as defined below) (and the shares or securities of every other person
subject to the foregoing restriction) until the end of such period.
1.18 c) The
Subscriber agrees not to issue any public statement with respect to the
Subscriber’s investment or proposed investment in the Company or the terms of
any agreement or covenant between them and the Company without the Company’s
prior written consent, except such disclosures as may be required under
applicable law or under any applicable order, rule or regulation.
(b) The
Company agrees not to disclose the names, addresses or any other information
about the Subscribers, except as required by law; provided, that the Company
may
use the name of the Subscriber for any offering or in any registration statement
filed pursuant to Article V in which the Subscriber’s shares are
included.
1.19 The
Subscriber agrees to hold the Company and its directors, officers, employees,
affiliates, controlling persons and agents and their respective heirs,
representatives, successors and assigns harmless and to indemnify them against
all liabilities, costs and expenses incurred by them as a result of (a) any
sale
or distribution of the Securities by the Subscriber in violation of the
Securities Act or any applicable state securities or “blue sky” laws; or (b) any
false representation or warranty or any breach or failure by the Subscriber
to
comply with any covenant made by the Subscriber in this Agreement (including
the
Confidential Investor Questionnaire contained in Article VII herein) or any
other document furnished by the Subscriber to any of the foregoing in connection
with this transaction.
5
1.21
If
the Subscriber is a corporation, limited partnership or limited liability
company, such Subscriber is validly existing corporation, limited partnership
or
limited liability company.
1.22
The
Subscriber acknowledges that no person or entity shall, as a result of the
purchase of the Units by the Subscriber, have any valid right, interest or
claim
against or upon the Company for any commission, fee or other compensation
pursuant to any agreement, arrangement or understanding entered into by or
on
behalf of the Subscriber.
II.
|
REPRESENTATIONS
BY AND COVENANTS OF THE COMPANY
|
The
Company hereby represents and warrants to the Subscriber that:
2.1 Organization,
Good Standing and Qualification.
The
Company is a corporation validly existing under the laws of the State of New
York and has full corporate power and authority to conduct its
business.
2.2 Capitalization
and Voting Rights.
The
authorized, issued and outstanding capital stock of the Company is as set forth
on Schedule 2.2 attached hereto and
all
issued and outstanding shares of the Company are validly issued, fully paid
and
nonassessable. Except as set forth in the Offering Materials, there are no
outstanding options, warrants, agreements, convertible securities, preemptive
rights or other rights to subscribe for or to purchase any shares of capital
stock of the Company. Except as set forth in the Offering Materials and as
otherwise required by law, there are no restrictions upon the voting or transfer
of any of the shares of capital stock of the Company pursuant to the Company’s
Amended Certificate of Incorporation (the “Certificate of Incorporation”),
By-Laws or other governing documents or any agreement or other instruments
to
which the Company is a party or by which the Company is bound.
2.3 Authorization;
Enforceability.
The
Company has all corporate right, power and authority to enter into this
Agreement and to consummate the transactions contemplated hereby. All corporate
action on the part of the Company, its directors and stockholders necessary
for
the (i) authorization execution, delivery and performance of this Agreement
by
the Company; and (ii) authorization, sale, issuance and delivery of the
Securities contemplated hereby and the performance of the Company’s obligations
hereunder has been taken. This Agreement has been duly executed and delivered
by
the Company and constitutes a legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, subject
to laws of general application relating to bankruptcy, insolvency and the relief
of debtors and rules of law governing specific performance, injunctive relief
or
other equitable remedies, and to limitations of public policy. The Common Stock,
when issued and fully paid for in accordance with the terms of this Agreement,
will be validly issued, fully paid and nonassessable. The issuance and sale
of
the Common Stock contemplated hereby will not give rise to any preemptive rights
or rights of first refusal on behalf of any person which have not been waived
in
connection with this offering.
6
2.4 No
Conflict; Governmental Consents.
(a) The
execution and delivery by the Company of this Agreement and the consummation
of
the transactions contemplated hereby will not result in the violation of any
material law, statute, rule, regulation, order, writ, injunction, judgment
or
decree of any court or governmental authority to or by which the Company is
bound, or of any provision of the Certificate of Incorporation or By-Laws of
the
Company, and will not conflict with, or result in a material breach or violation
of, any of the terms or provisions of, or constitute (with due notice or lapse
of time or both) a default under, any lease, loan agreement, mortgage, security
agreement, trust indenture or other agreement or instrument to which the Company
is a party or by which it is bound or to which any of its properties or assets
is subject, nor result in the creation or imposition of any lien upon any of
the
properties or assets of the Company.
(b) No
consent, approval, authorization or other order of any governmental authority
is
required to be obtained by the Company in connection with the authorization,
execution and delivery of this Agreement or with the authorization, issue and
sale of the Common Stock and Warrants, except such filings as may be required
to
be made with the SEC, NASD, NASDAQ and with any state or foreign blue sky or
securities regulatory authority.
2.5 Litigation.
The
Company knows of no pending or threatened legal or governmental proceedings
against the Company which could materially adversely affect the business,
property, financial condition or operations of the Company or which materially
and adversely questions the validity of this Agreement or any agreements related
to the transactions contemplated hereby or the right of the Company to enter
into any of such agreements, or to consummate the transactions contemplated
hereby or thereby. The Company is not a party or subject to the provisions
of
any order, writ, injunction, judgment or decree of any court or government
agency or instrumentality which could materially adversely affect the business,
property, financial condition or operations of the Company. There is no action,
suit, proceeding or investigation by the Company currently pending in any court
or before any arbitrator or that the Company intends to initiate.
2.6 Disclosure.
The
information set forth in the Offering Materials as of the date hereof contains
no untrue statement of a material fact nor omits to state a material fact
necessary in order to make the statements contained therein, in light of the
circumstances under which they were made, not misleading.
2.7 Investment
Company.
The
Company is not an “investment company” within the meaning of such term under the
Investment Company Act of 1940, as amended, and the rules and regulations of
the
SEC thereunder.
2.8
RESERVED
2.9 Intellectual
Property; Employees.
(i) The
Company has not received any written communications alleging that the Company
has violated or, by conducting its business as presently proposed to be
conducted, would violate any of the patents, trademarks, service marks, trade
names, copyrights or trade secrets or other proprietary rights of any other
person or entity.
7
(ii) The
Company is not aware that any of its employees is obligated under any contract
(including licenses, covenants or commitments of any nature) or other agreement,
or subject to any judgment, decree or order of any court or administrative
agency, that would interfere with their duties to the Company or that would
conflict with the Company’s business as presently conducted.
(iii) Neither
the execution nor delivery of this Agreement, nor the carrying on of the
Company’s business by the employees of the Company, nor the conduct of the
Company’s business as presently conducted, will, to the Company’s knowledge,
conflict with or result in a breach of the terms, conditions or provisions
of,
or constitute a default under, any contract, covenant or instrument under which
any employee is now obligated.
(iv) To
the
Company’s knowledge, no employee of the Company, nor any consultant with whom
the Company has contracted, is in violation of any term of any employment
contract, proprietary information agreement or any other agreement relating
to
the right of any such individual to be employed by, or to contract with, the
Company because of the nature of the business conducted by the Company; and
to
the Company’s knowledge the continued employment by the Company of its present
employees, and the performance of the Company’s contracts with its independent
contractors, will not result in any such violation. The Company has not received
any written notice alleging that any such violation has occurred. The Company
is
not aware that any officer, key employee or group of employees intends to
terminate his, her or their employment with the Company, nor does the Company
have a present intention to terminate the employment of any officer, key
employee or group of employees.
2.10 Title
to Properties and Assets; Liens, Etc.
The
Company has good and marketable title to its properties and assets, and good
title to its leasehold estates, in each case subject to no mortgage, pledge,
lien, lease, encumbrance or charge, other than (a) those resulting from taxes
which have not yet become delinquent; (b) liens and encumbrances which do not
materially detract from the value of the property subject thereto or materially
impair the operations of the Company; and (c) those that have otherwise arisen
in the ordinary course of business. The Company is in compliance with all
material terms of each lease to which it is a party or is otherwise
bound.
2.11
Use
of
Proceeds.
The net
proceeds of the sale of the Units shall be used
by
the
Company for working capital and general corporate purposes.
III.
|
TERMS
OF SUBSCRIPTION
|
3.1 The
Subscriber hereby authorizes and directs the Company to deliver the certificates
representing the Securities purchased by the Subscriber pursuant to this
Agreement directly to the Subscriber’s residential or business address indicated
on the signature page hereto.
IV.
|
CONDITIONS
TO OBLIGATIONS OF THE SUBSCRIBERS
|
4.1 The
Subscriber’s obligation to purchase the Units upon receipt of the Company’s
Notice is subject to the fulfillment as of the date of the receipt of the
Company’s Notice of the following conditions, which conditions may be waived at
the option of each Subscriber to the extent permitted by law:
(a) Covenants.
All
covenants, agreements and conditions contained in this Agreement to be performed
by the Company on or prior to the date of such Closing shall have been performed
or complied with in all material respects.
8
(b) No
Legal Order Pending.
There
shall not then be in effect any legal or other order enjoining or restraining
the transactions contemplated by this Agreement.
(c) No
Law
Prohibiting or Restricting Such Sale.
There
shall not be in effect any law, rule or regulation prohibiting or restricting
such sale or requiring any consent or approval of any person, which shall not
have been obtained, to issue the Securities (except as otherwise provided in
this Agreement).
V.
|
REGISTRATION
RIGHTS
|
5.1 Definitions.
As used
in this Agreement, the following terms shall have the following
meanings.
(a) The
term
“Holder” shall mean any person owning or having the right to acquire Registrable
Shares or any permitted transferee of a Holder.
(b) The
terms
“register”, “registered” and “registration” refer to a registration effected by
preparing and filing a registration statement or similar document in compliance
with the Securities Act of 1933, as amended (the “Securities Act”), and the
declaration or order of effectiveness of such registration statement or
document.
(c) The
term
“Registrable Shares” shall mean (i) the Common Stock and (ii) the Common Stock
issuable upon exercise of the Warrants provided, however, that securities shall
only be treated as Registrable Securities if and only for so long as they (A)
have not been disposed of pursuant to a registration statement declared
effective by the Securities and Exchange Commission (“SEC”); (B) have not been
sold in a transaction exempt from the registration and prospectus delivery
requirements of the Securities Act so that all transfer restrictions and
restrictive legends with respect thereto are removed upon the consummation
of
such sale; (C) are held by a Holder or a permitted transferee of a Holder
pursuant to Section 5.9; and (D) may not be disposed of under Rule 144(k) under
the Securities Act without restriction.
5.2
Registration Rights
(a) Subject
to the limitations set forth herein, in the event that the Company files a
registration statement other than a registration statement on Form S-8 is
declared effective by the Securities and Exchange Commission, at any time
beginning six months after the date such registration statement is declared
effective by the SEC, Subscribers may request the registration under the
Securities Act of 1933, as amended (the “1933 Act”) for all or a part of their
Registrable Securities then outstanding (a “Demand Registration”). The Company
shall use its commercially reasonable efforts to file such registration
statement under the 1933 Act within sixty days after the date any such request
is received by the Company, however, if the request is made during the last
forty five (45) days of the Company’s fiscal year, the Company shall not be
required to file the registration statement until ten (10) business days after
the Company’s Form 10-KSB has been filed with the SEC. The Company shall notify
the Subscribers promptly when any such registration statement has been declared
effective. The Company shall not be required to file more than one registration
statement pursuant to this Agreement.
9
(b) Notwithstanding
any other provision of this Section 5.2, the Company may at any time, abandon
or
delay any registration commenced by the Company. In the event of such an
abandonment by the Company, the Company shall not be required to continue
registration of shares requested by the Holder for inclusion, the Holder shall
retain the right to request inclusion of shares as set forth above and the
withdrawn registration shall not be deemed to be a registration request for
the
purposes of this Section.
5.3 Registration
Procedures.
Whenever required under this Article V to include Registrable Shares in a
Company registration statement, the Company shall, as expeditiously as
reasonably possible:
(a) Use
best
efforts to (i) cause such registration statement to become effective, and (ii)
cause such registration statement to remain effective until the earliest to
occur of (A) such date as the sellers of Registrable Shares (the “Selling
Holders”) have completed the distribution described in the registration
statement and (B) such time that all of such Registrable Shares are no longer,
by reason of Rule 144(k) under the Act, required to be registered for the sale
thereof by such Holders. The Company will also use its best efforts to, during
the period that such registration statement is required to be maintained
hereunder, file such post-effective amendments and supplements thereto as may
be
required by the Securities Act and the rules and regulations thereunder or
otherwise to ensure that the registration statement does not contain any untrue
statement of material fact or omit to state a fact required to be stated therein
or necessary to make the statements contained therein, in light of the
circumstances under which they are made, not misleading; provided, however,
that
if applicable rules under the Securities Act governing the obligation to file
a
post-effective amendment permits, in lieu of filing a post-effective amendment
that (i) includes any prospectus required by Section 10(a)(3) of the Securities
Act or (ii) reflects facts or events representing a material or fundamental
change in the information set forth in the registration statement, the Company
may incorporate by reference information required to be included in (i) and
(ii)
above to the extent such information is contained in periodic reports filed
pursuant to Section 13 or 15(d) of the Exchange Act in the registration
statement.
(b) Prepare
and file with the SEC such amendments and supplements to such registration
statement, and the prospectus used in connection with such registration
statement, as may be necessary to comply with the provisions of the Securities
Act with respect to the disposition of all securities covered by such
registration statement.
(c) Make
available for inspection upon reasonable notice during the Company’s regular
business hours by each Selling Holder, any underwriter participating in any
distribution pursuant to such registration statement, and any attorney,
accountant or other agent retained by such Selling Holder or underwriter, all
financial and other records, pertinent corporate documents and properties of
the
Company, and cause the Company’s officers, directors and employees to supply all
information reasonably requested by any such Selling Holder, underwriter,
attorney, accountant or agent in connection with such registration
statement.
10
(d) Furnish
to the Selling Holders such numbers of copies of a prospectus, including a
preliminary prospectus as amended or supplemented from time to time, in
conformity with the requirements of the Securities Act, and such other documents
as they may reasonably request in order to facilitate the disposition of
Registrable Shares owned by them.
(e) Use
best
efforts to register and qualify the securities covered by such registration
statement under such other federal or state securities laws of such
jurisdictions as shall be reasonably requested by the Selling Holders; provided,
however, that the Company shall not be required in connection therewith or
as a
condition thereto to qualify to do business or to file a general consent to
service of process in any such states or jurisdictions, unless the Company
is
already subject to service in such jurisdiction and except as may be required
by
the Securities Act.
(f) In
the
event of any underwritten public offering, enter into and perform its
obligations under an underwriting agreement, in usual and customary form, with
the managing underwriter of such offering. Each Selling Holder participating
in
such underwriting shall also enter into and perform its obligations under such
an agreement.
(g) Notify
each Holder of Registrable Shares covered by such registration statement, at
any
time when a prospectus relating thereto is required to be delivered under the
Securities Act, (i) when the registration statement or any post-effective
amendment and supplement thereto has become effective; (ii) of the issuance
by
the SEC of any stop order or the initiation of proceedings for that purpose
(in
which event the Company shall make every effort to obtain the withdrawal of
any
order suspending effectiveness of the registration statement at the earliest
possible time or prevent the entry thereof); (iii) of the receipt by the Company
of any notification with respect to the suspension of the qualification of
the
Registrable Shares for sale in any jurisdiction or the initiation of any
proceeding for such purpose; and (iv) of the happening of any event as a result
of which the prospectus included in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then
existing.
(h) Cause
all
such Registrable Shares registered hereunder to be listed on each securities
exchange or quotation service on which similar securities issued by the Company
are then listed or quoted.
(i) Provide
a
transfer agent and registrar for all Registrable Shares registered pursuant
hereunder and, if required, CUSIP number for all such Registrable Shares, in
each case not later than the effective date of such registration.
(j) Cooperate
with the Selling Holders and the managing underwriters, if any, to facilitate
the timely preparation and delivery of certificates representing the Registrable
Shares to be sold, which certificates will not bear any restrictive legends;
and
enable such Registrable Shares to be in such denominations and registered in
such names as the managing underwriters, if any, shall request at least two
business days prior to any sale of the Registrable Shares to the
underwriters.
11
(k) In
connection with an underwritten offering, cause the officers of the Company
to
provide reasonable assistance in the preparation of, any “road show”
presentation to potential investors as the managing underwriter may determine.
(l) Comply
with all applicable rules and regulations of the SEC.
(m) If
the
offering is underwritten and at the request of any Selling Holder, use its
best
efforts to furnish on the date that Registrable Shares are delivered to the
underwriters for sale pursuant to such registration: (i) opinions dated such
date of counsel representing the Company for the purposes of such registration,
addressed to the underwriters and the transfer agent for the Registrable Shares
so delivered, respectively, to the effect that such registration statement
has
become effective under the Securities Act and such Registrable Shares are freely
tradable, and covering such other matters as are customarily covered in opinions
of issuer’s counsel delivered to underwriters and transfer agents in
underwritten public offerings and (ii) a letter dated such date from the
independent public accountants who have certified the financial statements
of
the Company included in the registration statement or the prospectus, covering
such matters as are customarily covered in accountants’ letters delivered to
underwriters in underwritten public offerings.
5.4 Furnish
Information.
It
shall be a condition precedent to the obligation of the Company to take any
action pursuant to this Article V with respect to the Registrable Shares of
any
Selling Holder that such Holder shall furnish to the Company such information
regarding the Holder, the Registrable Shares held by the Holder, and the
intended method of disposition of such securities as shall be reasonably
required by the Company to effect the registration of such Holder’s Registrable
Shares.
5.5 Registration
Expenses.
The
Company shall bear and pay all Registration Expenses incurred in connection
with
any registration, filing or qualification of Registrable Shares with respect
to
registrations pursuant to Section 5.2 for each Holder, but excluding
underwriting discounts and commissions relating to Registrable Shares and
excluding any professional fees or costs of accounting, financial or legal
advisors to any of the Holders.
5.6 Underwriting
Requirements.
In
connection with any offering involving an underwriting of shares of the
Company’s capital stock, the Company shall not be required under Section 5.2 to
include any of the Holders’ Registrable Shares in such underwriting unless they
accept the terms of the underwriting as agreed upon between the Company and
the
underwriters selected by it (or by other persons entitled to select the
underwriters), and then only in such quantity as the underwriters determine
in
their sole discretion will not jeopardize the success of the offering by the
Company. If the total amount of securities, including Registrable Shares,
requested by stockholders to be included in such offering exceeds the amount
of
securities sold other than by the Company that the underwriters determine in
their sole discretion is compatible with the success of the offering, then
the
Company shall be required to include in the offering only that number of such
securities, including Registrable Shares, which the underwriters determine
in
their sole discretion will not jeopardize the success of the offering (the
securities so included to be apportioned pro rata among the selling stockholders
according to the total amount of securities entitled to be included therein
owned by each selling stockholder or in such other proportions as shall mutually
be agreed to by such selling stockholders). For purposes of the preceding
parenthetical concerning apportionment, for any selling stockholder who is
a
holder of Registrable Shares and is a partnership or corporation, the partners,
retired partners and stockholders of such holder, or the estates and family
members of any such partners and retired partners and any trusts for the benefit
of any of the foregoing persons shall be deemed to be a single “selling
stockholder”, and any pro-rata reduction with respect to such “selling
stockholder” shall be based upon the aggregate amount of shares carrying
registration rights owned by all entities and individuals included in such
“selling stockholder”, as defined in this sentence.
12
5.7 Delay
of Registration.
No
Holder shall have any right to obtain or seek an injunction restraining or
otherwise delaying any such registration as the result of any controversy that
might arise with respect to the interpretation or implementation of this
Article.
5.8 Indemnification.
In the
event that any Registrable Shares are included in a registration statement
under
this Article V:
(a) To
the
extent permitted by law, the Company will indemnify and hold harmless each
Holder, any underwriter (as defined in the Securities Act) for such Holder
and
each person, if any, who controls such Holder or underwriter within the meaning
of the Securities Act or the Exchange Act, against any losses, claims, damages,
or liabilities (joint or several) to which they may become subject under the
Securities Act, or the Exchange Act, insofar as such losses, claims, damages,
or
liabilities (or actions in respect thereof) arise out of or are based upon
any
of the following statements, omissions or violations (collectively a
“Violation”): (i) any untrue statement of a material fact contained in such
registration statement, including any preliminary prospectus or final prospectus
contained therein or any amendments or supplements thereto, (ii) the omission
to
state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading, or (iii) any violation by the
Company of the Securities Act, the Exchange Act, or any rule or regulation
promulgated under the Securities Act, or the Exchange Act, and the Company
will
pay to each such Holder, underwriter or controlling person, as incurred, any
legal or other expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, damage, liability, or action;
provided, however, that the indemnity agreement contained in this Section 5.8(a)
shall not apply to amounts paid in settlement of any such loss, claim, damage,
liability, or action if such settlement is effected without the consent of
the
Company (which consent shall not be unreasonably withheld), nor shall the
Company be liable in any such case for any such loss, claim, damage, liability,
or action to the extent that it arises out of or is based upon a Violation
which
occurs in reliance upon and in conformity with written information furnished
expressly for use in connection with such registration by any such Holder,
underwriter or controlling person.
(b) To
the
extent permitted by law, each Selling Holder will indemnify and hold harmless
the Company, each of its directors, each of its officers, each person, if any,
who controls the Company within the meaning of the Securities Act, any
underwriter, any other Holder selling securities in such registration statement
and any controlling person of any such underwriter or other Holder, against
any
losses, claims, damages, or liabilities (joint or several) to which any of
the
foregoing persons may become subject, under the Securities Act, or the Exchange
Act, insofar as such losses, claims, damages, or liabilities (or actions in
respect thereto) arise out of or are based upon any Violation, in each case
to
the extent (and only to the extent) that such Violation occurs in reliance
upon
and in conformity with written information furnished by such Holder expressly
for use in connection with such registration; and each such Holder will pay,
as
incurred, any legal or other expenses reasonably incurred by any person intended
to be indemnified pursuant to this Section 5.8(b), in connection with
investigating or defending any such loss, claim, damage, liability, or action;
provided,
however,
that
the indemnity agreement contained in this Section 5.8(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the consent of the Holder, which consent
shall not be unreasonably withheld; provided,
further,
that, in
no event shall any indemnity under this Section 5.8(b) exceed the greater of
the
cash value of the (i) gross proceeds from the offering received by such Holder
or (ii) such Holder’s investment pursuant to this Agreement as set forth on the
signature page attached hereto.
13
(c) Promptly
after receipt by an indemnified party under this Section 5.8 of notice of the
commencement of any action (including any governmental action), such indemnified
party shall, if a claim in respect thereof is to be made against any
indemnifying party under this Section 5.8, deliver to the indemnifying party
a
written notice of the commencement thereof and the indemnifying party shall
have
the right to participate in, and, to the extent the indemnifying party so
desires, jointly with any other indemnifying party similarly notified, to assume
the defense thereof with counsel selected by the indemnifying party and approved
by the indemnified party (whose approval shall not be unreasonably withheld);
provided, however, that an indemnified party (together with all other
indemnified parties which may be represented without conflict by one counsel)
shall have the right to retain one separate counsel, with the fees and expenses
to be paid by the indemnifying party, if representation of such indemnified
party by the counsel retained by the indemnifying party would be inappropriate
due to actual or potential differing interests between such indemnified party
and any other party represented by such counsel in such proceeding. The failure
to deliver written notice to the indemnifying party within a reasonable time
of
the commencement of any such action, if prejudicial to its ability to defend
such action, shall relieve such indemnifying party of any liability to the
indemnified party under this Section 5.8, but the omission so to deliver written
notice to the indemnifying party will not relieve it of any liability that
it
may have to any indemnified party otherwise than under this Section
5.8.
(d) If
the
indemnification provided for in this Section 5.8 is held by a court of competent
jurisdiction to be unavailable to an indemnified party with respect to any
loss,
liability, claim, damage, or expense referred to therein, then the indemnifying
party, in lieu of indemnifying such indemnified party hereunder, shall
contribute to the amount paid or payable by such indemnified party as a result
of such loss, liability, claim, damage, or expense in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the
one
hand and of the indemnified party on the other in connection with the statements
or omissions that resulted in such loss, liability, claim, damage, or expense
as
well as any other relevant equitable considerations. The relative fault of
the
indemnifying party and of the indemnified party shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a
material fact or the alleged omission to state a material fact relates to
information supplied by the indemnifying party or by the indemnified party
and
the parties’ relative intent, knowledge, access to information, and opportunity
to correct or prevent such statement or omission.
14
(e) Notwithstanding
the foregoing, to the extent that the provisions on indemnification and
contribution contained in the underwriting agreement entered into in connection
with the underwritten public offering are in conflict with the foregoing
provisions, the provisions in the underwriting agreement shall
control.
(f) The
obligations of the Company and Holders under this Section 5.8 shall survive
the
completion of any offering of Registrable Shares in a registration statement
under this Article V, and otherwise.
5.9 Permitted
Transferees.
The
rights to cause the Company to register Registrable Shares granted to the
Holders by the Company under this Article V may be assigned in full by a Holder
in connection with a transfer by such Holder of its Registrable Shares if:
(a) such Holder gives prior written notice to the Company; (b) such
transferee agrees to comply with the terms and provisions of this Agreement;
(c) such transfer is otherwise in compliance with this Agreement and
(d) such transfer is otherwise effected in accordance with applicable
securities laws. Except as specifically permitted by this Section 5.9, the
rights of a Holder with respect to Registrable Shares as set out herein shall
not be transferable to any other Person, and any attempted transfer shall cause
all rights of such Holder therein to be forfeited.
5.10 Termination
of Registration Rights
The
right of any Holder to request inclusion in any registration pursuant to Section
5.2 shall terminate if all shares of Registrable Shares held by such Holder
may
immediately be sold under Rule 144(k).
5.11 Removal
of Shares from Registration Statement In
the
event that any Registration Statement (the “Original Registration Statement”)
filed pursuant to this Agreement will not be declared effective due to comments
from the Securities and Commission, the Company in its sole reasonable
discretion may remove from Registration Statement all or any portion of the
number of shares of the Holder’s shares of Registrable Securities from such
Original Registration Statement as the Company in its reasonable discretion
deems appropriate.
VI.
|
MISCELLANEOUS
|
6.1 Any
notice or other communication given hereunder shall be deemed sufficient if
in
writing and sent by registered or certified mail, return receipt requested,
or
delivered by hand against written receipt therefor, addressed as
follows:
if
to the
Company, to it at:
Cornerstone
Pharmaceuticals, Inc.
000
Xxxxxxx Xxxxxx
Xxx
Xxxx,
XX 00000
Attn:
Xxxxx Xxxxxxxx, Esq.
15
With
a
copy to:
Sichenzia
Xxxx Xxxxxxxx Xxxxxxx LLP
0000
Xxxxxx xx xxx Xxxxxxxx
Xxx
Xxxx,
XX 00000
Attn:
Xxxx Xxxx, Esq.
if
to the
Subscriber, to the Subscriber’s address indicated on the signature page of this
Agreement.
Notices
shall be deemed to have been given or delivered on the date of mailing, except
notices of change of address, which shall be deemed to have been given or
delivered when received.
6.2 Except
as
otherwise provided herein, this Agreement shall not be changed, modified or
amended except by a writing signed by the parties to be charged, and this
Agreement may not be discharged except by performance in accordance with its
terms or by a writing signed by the party to be charged.
6.3 Subject
to the provisions of Section 5.9, this Agreement shall be binding upon and
inure
to the benefit of the parties hereto and to their respective heirs, legal
representatives, successors and assigns. This Agreement sets forth the entire
agreement and understanding between the parties as to the subject matter hereof
and merges and supersedes all prior discussions, agreements and understandings
of any and every nature among them.
6.4 Upon
the
execution and delivery of this Agreement by the Subscriber, this Agreement
shall
become a binding obligation of the Subscriber with respect to the purchase
of
Shares as herein provided, subject, however, to the right hereby reserved by
the
Company to enter into the same agreements with other subscribers and to add
and/or delete other persons as subscribers.
6.5 NOTWITHSTANDING
THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO,
THE
PARTIES EXPRESSLY AGREE THAT ALL THE TERMS AND PROVISIONS HEREOF SHALL BE
CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK
WITHOUT REGARD TO SUCH STATE’S PRINCIPLES OF CONFLICTS OF LAW. IN THE EVENT THAT
A JUDICIAL PROCEEDING IS NECESSARY, THE SOLE FORUM FOR RESOLVING DISPUTES
ARISING OUT OF OR RELATING TO THIS AGREEMENT IS THE SUPREME COURT OF THE STATE
OF NEW YORK IN AND FOR THE COUNTY OF NEW YORK OR THE FEDERAL COURTS FOR SUCH
STATE AND COUNTY, AND ALL RELATED APPELLATE COURTS, THE PARTIES HEREBY
IRREVOCABLY CONSENT TO THE JURISDICTION OF SUCH COURTS AND AGREE TO SAID VENUE.
6.6 In
order
to discourage frivolous claims the parties agree that unless a claimant in
any
proceeding arising out of this Agreement succeeds in establishing his claim
and
recovering a judgment against another party (regardless of whether such claimant
succeeds against one of the other parties to the action), then the other party
shall be entitled to recover from such claimant all of its/their reasonable
legal costs and expenses relating to such proceeding and/or incurred in
preparation therefor.
16
6.7 The
holding of any provision of this Agreement to be invalid or unenforceable by
a
court of competent jurisdiction shall not affect any other provision of this
Agreement, which shall remain in full force and effect. If any provision of
this
Agreement shall be declared by a court of competent jurisdiction to be invalid,
illegal or incapable of being enforced in whole or in part, such provision
shall
be interpreted so as to remain enforceable to the maximum extent permissible
consistent with applicable law and the remaining conditions and provisions
or
portions thereof shall nevertheless remain in full force and effect and
enforceable to the extent they are valid, legal and enforceable, and no
provisions shall be deemed dependent upon any other covenant or provision unless
so expressed herein. Moreover, said provision shall be replaced with language
that is as similar in business purpose and intent and one that shall be legal,
valid and enforceable
.It
is
agreed that a waiver by either party of a breach of any provision of this
Agreement shall not operate, or be construed, as a waiver of any subsequent
breach by that same party.
6.8 The
parties agree to execute and deliver all such further documents, agreements
and
instruments and take such other and further action as may be necessary or
appropriate to carry out the purposes and intent of this Agreement.
6.9 This
Agreement may be executed in two or more counterparts each of which shall be
deemed an original, but all of which shall together constitute one and the
same
instrument. This Agreement may also be executed via facsimile, which shall
be
deemed an original.
6.10 Nothing
in this Agreement shall create or be deemed to create any rights in any person
or entity not a party to this Agreement, except for the holders of Registrable
Shares.
6.12
The
obligations of each Subscriber under this Agreement are several and not joint
with the obligations of any other Subscriber, and no Subscriber shall be
responsible in any way for the performance of the obligations of any other
Subscriber under this Agreement. The decision of each Subscriber to purchase
the
Shares pursuant to this Agreement has been made by such Subscriber independently
of any other Subscriber. Nothing contained herein and no action taken by any
Subscriber pursuant thereto, shall be deemed to constitute the Subscribers
as a
partnership, an association, a joint venture or any other kind of entity, or
create a presumption that the Subscribers are in any way acting in concert
or as
a group with respect to such obligations or the transactions contemplated by
this Agreement. Each Subscriber acknowledges that no other Subscriber has acted
as agent for such Subscriber in connection with making its investment hereunder
and that no Subscriber will be acting as agent of such Subscriber in connection
with monitoring its investment in the Securities or enforcing its rights under
this Agreement. Each Subscriber shall be entitled to independently protect
and
enforce its rights, including, without limitation, the rights arising out of
this Agreement and it shall not be necessary for any other Subscriber to be
joined as an additional party in any proceeding for such purpose.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
17
CONFIDENTIAL
INVESTOR QUESTIONNAIRE
7.1 The
Subscriber represents and warrants that he, she or it comes within one category
marked below, and that for any category marked, he, she or it has truthfully
set
forth, where applicable, the factual basis or reason the Subscriber comes within
that category. ALL INFORMATION IN RESPONSE TO THIS SECTION WILL BE KEPT STRICTLY
CONFIDENTIAL. The undersigned agrees to furnish any additional information
which
the Company deems necessary in order to verify the answers set forth
below.
Category
A
|
____
|
|
The
undersigned is an individual (not a partnership, corporation, etc.)
whose
individual net worth, or joint net worth with his or her spouse,
presently
exceeds $1,000,000.
|
Explanation.
In calculating net worth you may include equity in personal property
and
real estate, including your principal residence, cash, short-term
investments, stock and securities. Equity in personal property
and real
estate should be based on the fair market value of such property
less debt
secured by such property.
|
|||
Category
B
|
____
|
The
undersigned is an individual (not a partnership, corporation, etc.)
who
had an income in excess of $200,000 in each of the two most recent
years,
or joint income with his or her spouse in excess of $300,000 in
each of
those years (in each case including foreign income, tax exempt
income and
full amount of capital gains and losses but excluding any income
of other
family members and any unrealized capital appreciation) and has
a
reasonable expectation of reaching the same income level in the
current
year.
|
|
Category
C
|
____
|
The
undersigned is a director or executive officer of the Company which
is
issuing and selling the Shares.
|
|
Category
D
|
____
|
The
undersigned is a bank; a savings and loan association; insurance
company;
registered investment company; registered business development
company;
licensed small business investment company (“SBIC”); or employee benefit
plan within the meaning of Title 1 of ERISA and (a) the investment
decision is made by a plan fiduciary which is either a bank, savings
and
loan association, insurance company or registered investment advisor,
or
(b) the plan has total assets in excess of $5,000,000 or (c) is
a self
directed plan with investment decisions made solely by persons
that are
accredited investors. (describe entity)
|
|
Category
E
|
____
|
|
The
undersigned is a private business development company as defined
in
section 202(a)(22) of the Investment Advisors Act of 1940. (describe
entity)
|
18
Category
F
|
____
|
The
undersigned is either a corporation, partnership, Massachusetts
business
trust, or non-profit organization within the meaning of Section
501(c)(3)
of the Internal Revenue Code, in each case not formed for the specific
purpose of acquiring the Shares and with total assets in excess
of
$5,000,000. (describe entity)
|
|
Category
G
|
____
|
The
undersigned is a trust with total assets in excess of $5,000,000,
not
formed for the specific purpose of acquiring the Shares, where
the
purchase is directed by a “sophisticated investor” as defined in
Regulation 506(b)(2)(ii) under the Act.
|
|
Category
H
|
____
|
The
undersigned is an entity (other than a trust) in which all of the
equity
owners are “accredited investors” within one or more of the above
categories. If relying upon this Category alone, each equity owner
must
complete a separate copy of this Agreement. (describe
entity)
|
|
Category
I
|
____
|
The
undersigned is not within any of the categories above and is therefore
not
an accredited investor.
|
|
The
undersigned agrees that the undersigned will notify the Company
at any
time on or prior to the Closing Date in the event that the representations
and warranties in this Agreement shall cease to be true, accurate
and
complete.
|
7.2 SUITABILITY
(please
answer each question)
(a) For
an
individual Subscriber, please describe your current employment, including the
company by which you are employed and its principal business:
(b) For
an
individual Subscriber, please describe any college or graduate degrees held
by
you:
(c) For
all
Subscribers, please list types of prior investments:
19
(d) For
all
Subscribers, please state whether you have you participated in other
private
placements
before:
YES_______
|
NO_______
|
(e) If
your
answer to question (d) above was “YES”, please indicate frequency of such prior
participation in private
placements
of:
Public
Companies
|
Private
Companies
|
Public
or Private
Biotechnology
Companies
|
|||
Frequently
|
|||||
Occasionally
|
|||||
Never
|
(f) For
individual Subscribers, do you expect your current level of income to
significantly decrease in the foreseeable future:
YES_______
|
NO_______
|
(g) For
trust, corporate, partnership and other institutional Subscribers, do you expect
your total assets to significantly decrease in the foreseeable future:
YES_______
|
NO_______
|
(h) For
all
Subscribers, do you have any other investments or contingent liabilities which
you reasonably anticipate could cause you to need sudden cash requirements
in
excess of cash readily available to you:
YES_______
|
NO_______
|
(i) For
all
Subscribers, are you familiar with the risk aspects and the non-liquidity of
investments such as the securities for which you seek to subscribe?
YES_______
|
NO_______
|
(j)
For all
Subscribers, do you understand that there is no guarantee of financial return
on
this investment and that you run the risk of losing your entire
investment?
YES_______
|
NO_______
|
7.3 MANNER
IN WHICH TITLE IS TO BE HELD.
(circle
one)
(a) |
Individual
Ownership
|
(b) |
Community
Property
|
(c) |
Joint
Tenant with Right of
Survivorship
(both parties
must
sign)
|
(d) |
Partnership*
|
(e) |
Tenants
in Common
|
(f) |
Company*
|
(g) |
Trust*
|
(h) |
Other
|
*If
Shares are being subscribed for by an entity, the attached Certificate of
Signatory must also be completed.
20
7.4 NASD
AFFILIATION.
Are
you
affiliated or associated with an NASD member firm (please check
one):
Yes
_________ No
__________
If
Yes,
please describe:
_________________________________________________________
_________________________________________________________
_________________________________________________________
*If
Subscriber is a Registered Representative with an NASD member firm, have the
following acknowledgment signed by the appropriate party:
The
undersigned NASD member firm acknowledges receipt of the notice required by
Article 3, Sections 28(a) and (b) of the Rules of Fair Practice.
_________________________________
Name
of
NASD Member Firm
By:
______________________________
Authorized
Officer
Date:
____________________________
7.5 The
undersigned is informed of the significance to the Company of the foregoing
representations and answers contained in the Confidential Investor Questionnaire
contained in this Article VII and such answers have been provided under the
assumption that the Company will rely on them.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
21
|
|
|
Signature
|
Signature
(if purchasing jointly)
|
|
|
|
|
Name
Typed or Printed
|
Name
Typed or Printed
|
|
|
|
|
Entity
Name
|
Entity
Name
|
|
|
|
|
Address
|
Address
|
|
|
|
|
City,
State and Zip Code
|
City,
State and Zip Code
|
|
|
|
|
Telephone-Business
|
Telephone—Business
|
|
|
|
|
Telephone-Residence
|
Telephone--Residence
|
|
|
|
|
Facsimile-Business
|
Facsimile--Business
|
|
|
|
|
Facsimile-Residence
|
Facsimile--Residence
|
|
|
|
|
Tax
ID # or Social Security #
|
Tax
ID # or Social Security #
|
|
Name
in which securities should be issued:
|
|
Dated:
_______________ ,
2006
This
Subscription Agreement is agreed to and accepted as of
________________ ,
2006.
CORNERSTONE PHARMACEUTICALS, INC. | |
By:____________________________________
Name:
Title:
|
CERTIFICATE
OF SIGNATORY
(To
be
completed if Shares are
being
subscribed for by an entity)
I,____________________________,
am the____________________________ of __________________________________________
(the “Entity”).
I
certify
that I am empowered and duly authorized by the Entity to execute and carry
out
the terms of the Subscription Agreement and to purchase and hold the Shares,
and
certify further that the Subscription Agreement has been duly and validly
executed on behalf of the Entity and constitutes a legal and binding obligation
of the Entity.
IN
WITNESS WHEREOF, I have set my hand this ________ day of _________________,
______
_______________________________________
(Signature)
|
2
Schedule
2.2
CAPITALIZATION
I. Authorized
(i)
|
40,000,000
shares of Common Stock, par value $.001 per
share.
|
(ii)
|
10,000,000
shares of Preferred Stock, par value $0.001 per share of which 6,050,000
shares have been designated as Series A Convertible Preferred
Stock.
|
II. Outstanding*
A.
|
Stockholder
|
Shares
of Common Stock
|
Altira
Capital & Consulting, L.L.C.
|
6,752,541
|
|
|
|
|
Misc.
Common Stockholders
|
10,425,841
|
|
17,178,382
|
||
B.
|
3,057,500
shares of Series A Convertible Preferred Stock held by various
stockholders.
|
III. Options
and Warrants
.
A. |
7,170,345
investor warrants, of which: 112,500 exercisable at $1.00 per share;
2,735,000 exercisable at $1.10 per share; 2,110,000 exercisable at
$1.25
per share; 378,415 exercisable at $1.38 per share, 430,431 exercisable
at
$1.78 per share and 930,000 exercisable at $2.00 per share and 474,000
are
exercisable at $3.50 per share.
|
B. |
478,304
broker and misc. warrants issued in conjunction with prior financings
and
misc. transactions.
|
C. |
2,500,000
Options approved for use as part of the Cornerstone Pharmaceuticals,
Inc.
2005 Incentive Stock Plan.
|
3